Kezar Life Sciences Inc. (KZR)
5.70
-0.01 (-0.18%)
At close: Mar 03, 2025, 3:59 PM
5.70
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST
Kezar Life Sciences Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 35.49M | 40.46M | 62.88M | 21.23M | 14.95M | 24.18M | 51.03M | 9.75M |
| Short-Term Investments | 165.88M | 236.1M | 145.47M | 119.22M | 63.26M | 83.25M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 13K | 13K |
| Other Long-Term Assets | 5.59M | 674K | 282K | 282K | 282K | 282K | 343K | 62K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | 2.5M | 1.97M | 1.24M | n/a | n/a | n/a |
| Other Current Assets | 5.58M | 9.16M | 3.3M | 4.36M | 2.93M | 2.37M | 1.29M | 740K |
| Total Current Assets | 206.95M | 285.72M | 211.65M | 144.81M | 81.13M | 109.81M | 52.33M | 10.49M |
| Property-Plant & Equipment | 8.69M | 13.17M | 6M | 6.75M | 8.1M | 4.59M | 1.54M | 862K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 14.29M | 13.85M | 6.28M | 7.03M | 8.38M | 4.88M | 1.9M | 937K |
| Total Assets | 221.24M | 299.57M | 217.93M | 151.84M | 89.51M | 114.68M | 54.22M | 11.42M |
| Account Payables | 8.25M | 2.48M | 2.03M | 2.36M | 823K | 193K | 547K | 466K |
| Deferred Revenue | n/a | n/a | n/a | 3.02M | 4.22M | 354K | n/a | n/a |
| Short-Term Debt | 3.01M | 5.13M | 2.4M | 2.08M | 1.8M | n/a | n/a | n/a |
| Other Current Liabilities | 6.48M | 3.39M | 3.79M | 2M | 3.38M | 3.14M | 937K | 185K |
| Total Current Liabilities | 17.74M | 11M | 8.21M | 6.44M | 6M | 3.34M | 1.48M | 651K |
| Long-Term Debt | 15.92M | 18.7M | 12.85M | 8.84M | 10.93M | n/a | n/a | n/a |
| Other Long-Term Liabilities | n/a | n/a | n/a | -4.42M | -5.46M | 2.55M | 78.42M | 28.2M |
| Total Long-Term Liabilities | 15.92M | 18.7M | 12.85M | 4.42M | 5.46M | 2.55M | 78.42M | 28.2M |
| Total Liabilities | 33.66M | 29.7M | 21.06M | 10.86M | 11.47M | 5.88M | 79.91M | 28.85M |
| Total Debt | 18.93M | 21.26M | 14.04M | 5.46M | 6.36M | n/a | n/a | n/a |
| Common Stock | 73K | 68K | 56K | 46K | 19K | 19K | 1K | 1K |
| Retained Earnings | -350.76M | -248.89M | -180.65M | -126.02M | -84.28M | -49.2M | -26.03M | -17.51M |
| Comprehensive Income | -130K | -923K | -291K | -137K | -196K | -203K | -111K | -150K |
| Shareholders Equity | 187.57M | 269.87M | 196.88M | 140.98M | 78.05M | 108.8M | -25.69M | -17.43M |
| Total Investments | 165.88M | 236.1M | 145.47M | 119.22M | 63.26M | 83.25M | 13K | 13K |